To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Myeloid leukemia cell differentiation protein (MCL1); eukaryotic translation initiation factor 4B (EIF4B)

Cancer

INDICATION: Breast cancer

Patient sample and cell studies suggest inhibiting EIF4B or MCL1 could help treat basal

Read the full 164 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE